Our Portfolio

Tailwind Capital and Abode Healthcare

ICG Enterprise identified Tailwind as an attractive investment partner for its US investment programme. It has a strong market reputation, an experienced team and focuses on sectors which have strong defensive growth characteristics. ICG Enterprise committed $15 million to Tailwind III in June 2018 and co-invested $6 million alongside the fund in Abode Healthcare in July 2018. 

Abode was sold to Summit Partners in August 2019. The sale occurred significantly earlier than planned - it was identified as a strategically important ‘must-have’ platform in the space and therefore able to command a premium valuation. The sale generated a return of 2.0x cost representing a gross IRR of 69%.

Tailwind Capital is a US private equity firm, which invests in growth-oriented, middle market companies. It invests in targeted sectors within healthcare, business services and industrial services. Its core focus in on companies with enterprise values up to $300 million. It completed fundraising for Tailwind III in September 2018, raising $1.75 billion, which was ahead of its target. At the final close, the fund was c. 15% invested

Having committed to the fund, ICG Enterprise was offered the opportunity to co-invest in Abode Healthcare, which provides hospice and home-care services in the United States. Demand is supported by strong demographic trends: the number of over 65’s in the US population is expected to grow by 44% over the next 20 years. Hospice care offers significant cost benefits over hospitalisation, but is also increasingly the preferred choice of patients.

Situations such as this fit well with our strategy, allowing us to deploy capital in high-conviction investment opportunities whilst growing our primary investment programme in the US. We believe that Abode is a good example of a defensive growth asset which is not sensitive to the economic cycle. 

More case studies

Share price (ICGT)

34.00P (3.23%)
3:02AM 17 May 2022
The share price information is delayed by at least 15 minutes

Net Asset Value

As of 31 January 2022
Full year results for the twelve months ended 31 January 2022
Year Net assets NAV per share Share price Dividends per share
Jan 2021 £952m 1,384p 966p 24p
Jan 2020 £794m 1,152p 966p 23p
Jan 2019 £731m 1,057p 822p 22p
Jan 2018 £664m 959p 818p 21p
Jan 2017 £613m 871p 698p 20p
Jan 2016 £521m 731p 545p 11p
Jan 2015 £507m 695p 575p 15.5p
Jan 2014 £494m 677p 563p 15.5p
Jan 2013 £460m 631p 487p 5p
Jan 2012 £415m 569p 357p 5p
Jan 2011 £389m 534p 308p 2.25p
Dec 2009 £338m 464p 305p 2.25p
Dec 2008 £327m 449p 187p 4.5p